Eric Heinrich, MD
Orthopaedic Surgery · Austin, TXNPI 1518937952
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $676,200 of the $907,486 with a category attached, or 74.5%. Encore Medical, LP accounts for 78.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $209,676 and has fallen 72.2% since, to $58,213 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 267 payments — averaging $3398.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$708K
- Orthalign Inc$198K
- Medical Device Business Services, Inc.$1K
- Carbofix Orthopedics Inc$118
- Abbott$71
- Medacta USA, Inc.$67
- plus $247 from 9 others
Across 131 payments — averaging $1263.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$117K
- Zimmer Biomet$48K
- Conformis, Inc.$700
Across 6 payments — averaging $8333.33 each. An ownership or investment interest held by the physician or an immediate family member.
- Orthalign Inc$50K
What the payments were for
- Royalty or licence$676,20075%
- Consulting fees$193,31921%
- Speaking & faculty fees$6,4001%
- Travel & lodging$26,0423%
- Food & beverage$5,5261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 186 | $708,023 |
| Orthalign Inc | 61 | $197,860 |
| Medical Device Business Services, Inc. | 4 | $1,100 |
| Carbofix Orthopedics Inc | 1 | $118 |
| Abbott | 4 | $71 |
| Medacta USA, Inc. | 1 | $67 |
| Stryker | 1 | $62 |
| Baxter Healthcare | 1 | $48 |
| Heron Therapeutics, Inc. | 2 | $33 |
| Johnson & Johnson | 1 | $23 |
| Zimmer Biomet | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Davol Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$231,085
- ORTHALIGN PLUS$161,522
- DJO Surgical TaperFill Hip System$125,870
- DJO Surgical Empowr Knee System$72,967
- DJO Surgical AltiVate Anatomic System$49,125
- OrthAlign Plus System$35,686
- DJO Surgical Exprt Revision Hip$25,260
- DJO Surgical FMP Acetabular System$24,000
- DJO Surgical Linear Hip System$7,666
- DJO Surgical 3DKnee System$1,579
- CORAIL$1,100
- DJO Surgical Cobalt HV Bone Cement$1,003
How this compares
$907,486 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 243 | $2,475 |
| Celecoxib | 143 | $1,553 |
| Enoxaparin Sodium | 21 | $1,497 |
| Sulindac | 120 | $1,383 |
| ErythromycinErythromycin Base | 26 | $1,165 |
| Cephalexin | 143 | $741 |
| Cefadroxil | 117 | $691 |
| Ondansetron OdtOndansetron | 125 | $566 |
| Tramadol Hcl | 135 | $446 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $312 |
| Diclofenac Sodium | 21 | $255 |
| Gabapentin | 26 | $132 |
| Meloxicam | 24 | $83 |
| Doxycycline Hyclate | 18 | $80 |
| Clindamycin Hcl | 16 | $72 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Austin
- Robert GrahamAustin$6.3M
- David DodginAustin$704K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.